Toward Clinical Translation of Human Ventricular Progenitor Cells for Cardiac Regeneration
During a heart attack, part of the heart muscle dies. A scar usually forms in its place, because the adult heart can hardly replace lost tissue. As a result, some patients develop heart failure. Medication can slow it down but cannot cure it.
Before birth, the heart develops from so-called progenitor cells. The group discovered that these cells can detect damaged areas of the heart, migrate there in a targeted way and repair the damage by maturing into new heart muscle cells on site. In pig hearts, lab-grown progenitor cells prevented heart failure from getting worse.
This project aims to bring this potential treatment closer to patients. Using electrophysiological cardiac catheter studies and small heart monitors placed under the skin, the scientists will test whether the new cells beat in synchrony with the heart or cause irregular heart rhythms. They will also study how the cells connect and interact with the existing heart tissue and how best to deliver them to the heart. The goal is to advance this type of cell therapy for people with heart failure.